Hearing News Watch

SAN DIEGO, CALIFORNIA – Ting Therapeutics, a privately-held company focused on advancing novel and repurposed molecules to address multiple causes of hearing loss, has been awarded a NIH SBIR phase II grant related to antibiotics-induced hearing loss. This award is in part based on a new publication in the latest issue of the prestigious journal Science Translational Medicine (Impact Factor

EDEN PRAIRIE, MINNESOTA – Starkey and SoundGear are proud to announce the successful sponsorship of the recent ARCA Menards Shore Lunch 250 held at the Elko Speedway. The event featured NASCAR rising star William Sawalich, who delivered a dominant performance on the track finishing in first place. Sawalich, driver of the #18 car for Joe Gibbs Racing and supported by

PALM BEACH GARDENS, FLORIDA — Leading hearing care retailer HearUSA today announced the opening of a new state-of-the-art Hearing Center of the Future in the Springtown area of San Marcos, Texas, at 199 Springtown Way, Unit 12. The opening is part of HearUSA’s initiative to expand access to Simply Excellent Hearing Care through the latest prescription and over-the-counter (OTC) hearing

CHADDS FORD, PENNSYLVANIA – CQ Partners has announced that Olympian and cancer survivor Chaunté Lowe will deliver the keynote address at the industry event, Reconnect ’25. Lowe will kick off Reconnect “with her positive, can-do attitude, empowering attendees throughout the event”. Reconnect ’25 will take place from February 27 to March 2, 2025, at the Omni Amelia Island Resort in

SEATTLE, WASHINGTON — Sound Pharmaceuticals has announced the completion of the Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease (STOPMD-3). SPI-1005, an oral capsule taken twice daily, is the only potential therapeutic to show significant improvement in hearing loss and tinnitus in Meniere’s Disease patients, as demonstrated in two previous studies. The STOPMD-3 study enrolled

MILAN, ITALY — Amplifon S.p.A. has reported robust financial results for the first half of 2024, demonstrating significant growth in revenues and profitability. The company achieved consolidated revenues of €1.177 billion (approximately $1.28 billion USD), marking an 8% increase at constant exchange rates and a 5.7% increase at current exchange rates compared to the first half of 2023. This growth

COPENHAGEN, DENMARK – Oticon A/S has launched a clinical research partnership with the Division of Audiology at Detroit, Michigan-based Henry Ford Health, one of the leading integrated and academic healthcare systems in the United States. The collaboration aims to generate valuable insights into post-fitting outcomes and hearing aid user experiences. The Oticon Clinical Research Team will work with Henry Ford

Researchers have made significant progress in understanding how to reduce the harmful side effects of cisplatin, a common chemotherapy drug. Cisplatin is known for its effectiveness against various cancers but also for its severe side effects, especially hearing loss (ototoxicity) and kidney damage (nephrotoxicity). A recent study, led by a team from the National Institutes of Health (NIH) and other

EDEN PRAIRIE, MINNESOTA – Starkey has announced that the company has been awarded the prestigious 2024 National Access Award by the Hearing Loss Association of America (HLAA) last month. The award was presented at the recent HLAA Convention in Phoenix, Arizona and accepted by Dave Fabry, Ph.D., Starkey’s Chief Hearing Health Officer. The HLAA National Access Award was presented to Starkey in

The conference program for the 68th International Congress of Hearing Aid Acousticians is now available, featuring exciting lectures from outstanding speakers. This year, the focus is on Denmark, the partner country, highlighting their contributions to the field. Participants in the 68th EUHA Congress, set for October 16-18, 2024, in Hanover, can expect a comprehensive program featuring the latest in hearing